Related references
Note: Only part of the references are listed.Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver
Giovanni Musso et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease
X. Jin et al.
DIGESTIVE AND LIVER DISEASE (2009)
Targeting the AMPK pathway for the treatment of Type 2 diabetes
Benoit Viollet et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Transcription Factor 7-Like 2 Polymorphism Modulates Glucose and Lipid Homeostasis, Adipokine Profile, and Hepatocyte Apoptosis in NASH
Giovanni Musso et al.
HEPATOLOGY (2009)
Reduction of Hepatic Steatosis in Rats and Mice After Treatment with a Liver-Targeted Thyroid Hormone Receptor Agonist
Edward E. Cable et al.
HEPATOLOGY (2009)
Differential MicroRNA Expression Between Hepatitis B and Hepatitis C Leading Disease Progression to Hepatocellular Carcinoma
Shunsuke Ura et al.
HEPATOLOGY (2009)
Unsaturated Fatty Acids Inhibit the Expression of Tumor Suppressor Phosphatase and Tensin Homolog (PTEN) Via MicroRNA-21 Up-regulation in Hepatocytes
Manlio Vinciguerra et al.
HEPATOLOGY (2009)
MicroRNAs Involved in Tumor Suppressor and Oncogene Pathways: Implications for Hepatobiliary Neoplasia
Justin L. Mott
HEPATOLOGY (2009)
A Novel Pregnane X Receptor and S14-Mediated Lipogenic Pathway in Human Hepatocyte
Amelie Moreau et al.
HEPATOLOGY (2009)
Role of Adenosine Monophosphate-Activated Protein Kinase-p70 Ribosomal S6 Kinase-1 Pathway in Repression of Liver X Receptor-Alpha-Dependent Lipogenic Gene Induction and Hepatic Steatosis by a Novel Class of Dithiolethiones
Seong Hwan Hwahng et al.
HEPATOLOGY (2009)
Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
Bo Kong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Activation of the Nuclear Receptor PXR Decreases Plasma LDL-Cholesterol Levels and Induces Hepatic Steatosis in LDL Receptor Knockout Mice
Menno Hoekstra et al.
MOLECULAR PHARMACEUTICS (2009)
Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes
Niresh Hariparsad et al.
NUCLEIC ACIDS RESEARCH (2009)
Regulating the regulators: mechanisms controlling the maturation of microRNAs
Xavier C. Ding et al.
TRENDS IN BIOTECHNOLOGY (2009)
The tangle of nuclear receptors that controls xenobiotic metabolism and transport: Crosstalk and consequences
Jean-Marc Pascussi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
Aurora Esquela-Kerscher et al.
CELL CYCLE (2008)
MicroRNAs: role in cardiovascular biology and disease
Chunxiang Zhang
CLINICAL SCIENCE (2008)
Increased expression and activity of the transcription factor FOX01 in nonalcoholic steatohepatitis
Luca Valenti et al.
DIABETES (2008)
Exenatide prevents fat-induced insulin resistance and raises adiponectin expression and plasma levels
L. Li et al.
DIABETES OBESITY & METABOLISM (2008)
Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients
H. Boon et al.
DIABETOLOGIA (2008)
Selective thyromimetics for atherosclerosis and dyslipidaemia: another old target making progress
Keith Suckling
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Thyroid hormone (T3) and TRβ agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats
Andrea Perra et al.
FASEB JOURNAL (2008)
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
Jie Zhou et al.
GASTROENTEROLOGY (2008)
Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
Onpan Cheung et al.
HEPATOLOGY (2008)
Alpha-Lipoic Acid Decreases Hepatic Lipogenesis Through Adenosine Mono phosphate-Activated Protein Kinase (AMPK)-Dependent and AMPK-Independent Pathways
Keun-Gyu Park et al.
HEPATOLOGY (2008)
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
Yannick Ladeiro et al.
HEPATOLOGY (2008)
Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response
Yan-Dong Wang et al.
HEPATOLOGY (2008)
Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle
Eric B. Taylor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Widespread changes in protein synthesis induced by microRNAs
Matthias Selbach et al.
NATURE (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
Targeting bile-acid signalling for metabolic diseases
Charles Thomas et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Effects of thyroid hormone analogs on lipid metabolism and thermogenesis
Miriam O. Ribeiro
THYROID (2008)
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Anders Berkenstam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
miRBase: tools for microRNA genomics
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2008)
Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat-fed mice
Benjamin J. Lamont et al.
DIABETES (2008)
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
David C. Klonoff et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation
Diane H. Song et al.
GASTROENTEROLOGY (2007)
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
Paula L. McClean et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes
Su-Jin Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Interferon modulation of cellular microRNAs as an antiviral mechanism
Irene M. Pedersen et al.
NATURE (2007)
Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase
Qu Fan Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets
V. A. Gault et al.
DIABETOLOGIA (2007)
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Sibylle Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver
Kouichi Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Tanya Hansotia et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The role of triiodothyronine-induced substrate cycles in the hepatic response to overnutrition: Thyroid hormone as an antioxidant
Neville Grant
MEDICAL HYPOTHESES (2007)
CAR and PXR: The xenobiotic-sensing receptors
Yoav E. Timsit et al.
STEROIDS (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Pancreatic and extrapancreatic effects of gastric inhibitory polypeptide
Yuichiro Yamada et al.
DIABETES (2006)
Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase
Marianne Suter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Incretin mimetics as a novel therapeutic option for hepatic steatosis
Maarten E. Tushuizen et al.
LIVER INTERNATIONAL (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice
Mengwei Zang et al.
DIABETES (2006)
Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro
Emma L. Haughton et al.
GASTROENTEROLOGY (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1α
Ji Miao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats
JB Majithiya et al.
LIFE SCIENCES (2006)
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
T Arsov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
T Inagaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
C Esau et al.
CELL METABOLISM (2006)
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
XK Ding et al.
HEPATOLOGY (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
SH Koo et al.
NATURE (2005)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Pregnenolone-16α-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms
CJ Marek et al.
BIOCHEMICAL JOURNAL (2005)
Long-term AICAR administration and exercise prevents diabetes in ZDF rats
R Pold et al.
DIABETES (2005)
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
LS Szczepaniak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1 alpha
RS Savkur et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Y Minokoshi et al.
NATURE (2004)
Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection
Y Nishino et al.
CARDIOVASCULAR RESEARCH (2004)
β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes
RP Robertson et al.
DIABETES (2004)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
YQ Zhang et al.
GENES & DEVELOPMENT (2004)
Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes
S Kodama et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets
A Zhao et al.
DNA AND CELL BIOLOGY (2004)
Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes
C Wolfrum et al.
NATURE (2004)
Adiponectin-mediated modulation of hypertrophic signals in the heart
R Shibata et al.
NATURE MEDICINE (2004)
Dietary fat and the risk of clinical type 2 diabetes - The European Prospective Investigation of Cancer-Norfolk study
AH Harding et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Y Horie et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1α -: Functional implications in hepatic cholesterol and glucose metabolism
S Bhalla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1
K Yamagata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
M Watanabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
T Claudel et al.
GASTROENTEROLOGY (2003)
A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR
M Downes et al.
MOLECULAR CELL (2003)
AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats
MA Iglesias et al.
DIABETES (2002)
Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats
R Bergeron et al.
DIABETES (2001)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Share Paper
